Atrial Fibrillation Clinical Trials in Toronto, Ontario
9 recruitingToronto, Ontario, Canada
Showing 1–9 of 9 trials
Recruiting
Not Applicable
The Fourth Left Atrial Appendage Occlusion Study
Atrial FibrillationStroke, IschemicSystemic Embolism
Hamilton Health Sciences Corporation4,000 enrolled127 locationsNCT05963698
Recruiting
Phase 2
A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation
Atrial Fibrillation
Novartis Pharmaceuticals165 enrolled30 locationsNCT07217067
Recruiting
Not Applicable
RAFT - Pace &Ablate
Heart FailureAtrial FibrillationPacemaker+1 more
Habib Khan600 enrolled12 locationsNCT06299514
Recruiting
Phase 3
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
Atrial FibrillationStrokeBleeding
Icahn School of Medicine at Mount Sinai3,200 enrolled101 locationsNCT04045665
Recruiting
Reversal of Atrial Substrate to Prevent Atrial Fibrillation Cohort Study
Atrial Fibrillation, Paroxysmal or Persistent
Ratika Parkash198 enrolled7 locationsNCT06249269
Recruiting
Not Applicable
Evaluation of MRI-conditional 12-lead ECG
Atrial Fibrillation
Dr. Graham Wright40 enrolled1 locationNCT04247685
Recruiting
Not Applicable
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
Atrial Fibrillation (AF)VTE
McMaster University920 enrolled14 locationsNCT06957366
Recruiting
Not Applicable
Characterization of Arrhythmia Substrate to Ablate Persistent Atrial Fibrillation
Atrial Fibrillation
Ottawa Heart Institute Research Corporation502 enrolled15 locationsNCT03347227
Recruiting
Phase 3
MAGNAM Trial, Magnesium Versus Amiodarone in Atrial Fibrillation in Critical Care
Atrial Fibrillation New Onset
Sunnybrook Health Sciences Centre200 enrolled5 locationsNCT05287191